Region: Global
Category: General Pharmaceuticals

Global General Pharmaceuticals

(638 reports matching your criteria)
  • 2025 Nonprescription Drugs and Over-The-Counter Medications Wholesale Global Market Size & Growth Report with Updated Analysis & Forecasts

    ... East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies with wholesale sales of nonprescription ... Read More

  • Global Legal Cannabis Market 2025-2029

    ... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More

  • Global Astaxanthin Market – Sources, Technologies and Applications

    ... various health conditions, including inflammation, diabetes, cardiovascular issues, vision problems, and central nervous system disorders. Widely utilized across industries, astaxanthin is used in aquaculture to enhance the pigmentation of salmon, trout, and shrimp; in nutraceuticals ... Read More

  • Healthcare Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033

    ... The rising healthcare expenditure, growing aging population, stringent regulatory standards, constant technological advancements, increasing focus on patient safety, and rapid growth in the pharmaceutical industry are some of the major factors propelling the market. Healthcare ... Read More

  • Betaine

    ... 4.6% over the analysis period 2024-2030. Synthetic Betaine, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth ... Read More

  • Track Etched Membranes

    ... at a CAGR of 10.1% over the analysis period 2024-2030. Membrane Filters, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$855.4 Million by the end of ... Read More

  • Synthetic Antioxidants

    ... CAGR of 6.1% over the analysis period 2024-2030. Liquid Antioxidants, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More

  • Sodium Alginate

    ... CAGR of 5.0% over the analysis period 2024-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$137.4 Million by the end of the analysis ... Read More

  • Lactoferrin

    ... 7.0% over the analysis period 2024-2030. Iron Absorption Function, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$161.1 Million by the end of the analysis period. ... Read More

  • Healthcare Distribution

    ... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More

  • Active Pharmaceutical Ingredients (API)

    ... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative APIs, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the ... Read More

  • Curcumin

    ... 8.7% over the analysis period 2024-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. Growth ... Read More

  • Cannabis Edibles

    ... CAGR of 22.0% over the analysis period 2024-2030. Solid Cannabis Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the ... Read More

  • Oral Solid Dosage Forms (OSDF) and Pharma Excipients

    ... 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% ... Read More

  • Downstream Processing

    ... CAGR of 15.6% over the analysis period 2024-2030. Purification Technique, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis ... Read More

  • Insoluble Dietary Fibers

    ... at a CAGR of 8.0% over the analysis period 2024-2030. Cellulose, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$1.9 Billion by the end of the ... Read More

  • Vial Adaptors for Reconstitution Drug

    ... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More

  • Potassium Bromide

    ... CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.5 Million While China is Forecast to Grow at 7.8% CAGR The Potassium Bromide market in the U.S. is estimated at ... Read More

  • Polyethylene Glycol Market by Grade, Form (Liquid, White wax, Flake/Powder), Package Size (Drums, Bulk Container, Glass Bottles), End-Use Industry (Pharmaceutical, Cosmetics & Personal care, Food & Beverage, Industrial) & Region - Global Forecast to 2029

    ... widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in ... Read More

  • Medical Membranes

    ... CAGR of 7.7% over the analysis period 2024-2030. Ultrafiltration Technology, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More

  • Glucose, Dextrose, and Maltodextrin

    ... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 Billion by the end ... Read More

  • Aseptic Sampling

    ... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More

  • Aseptic Processing

    ... CAGR of 3.5% over the analysis period 2024-2030. Vials & Ampoules Packaging, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$51.3 Billion by the end of ... Read More

  • Triacetin

    ... 4.3% over the analysis period 2024-2030. Triacetin Plasticizer, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$193.2 Million by the end of the analysis period. Growth ... Read More

  • Sodium Bromide

    ... CAGR of 6.2% over the analysis period 2024-2030. Powdered Sodium Bromide, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings